Expense

PetVivo Reports Third Quarter of Fiscal 2024 Financial Results

Retrieved on: 
Monday, February 12, 2024
Conference call, Expense, EDINA, Marketing, Average cost, Animal, Sale, MWI, Nine Months, Webcast, Three Months, Research, Cryptocurrency

EDINA, MN, Feb. 12, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the three months ended December 31, 2023 (“third quarter of 2024”).

Key Points: 
  • Conference call begins at 4:00 p.m. Central time today
    EDINA, MN, Feb. 12, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the three months ended December 31, 2023 (“third quarter of 2024”).
  • “We are excited about the progress the Company has made this past quarter, including the addition of Covetrus North America, LLC.
  • (Covetrus), to distribute our products beginning in January 2024,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc.
  • Cost of sales were $183,087 and $223,687 for the three months ended December 31, 2023 and 2022, respectively.

Corporate Plastic Power: Latest Upgraded Points Survey Examines How Employees Actually Use Their Company Credit Cards

Retrieved on: 
Tuesday, January 30, 2024
Transport, Expense, Organization, Reward, Meal, Research, Travel, Cryptocurrency

AUSTIN, Texas, Jan. 30, 2024 /PRNewswire/ -- Upgraded Points recently revealed its latest research findings with a fascinating glimpse into the topic of employees' use of company-issued credit cards. The study identifies the role, usage, and challenges these cards present in a modern workplace.

Key Points: 
  • AUSTIN, Texas, Jan. 30, 2024 /PRNewswire/ -- Upgraded Points recently revealed its latest research findings with a fascinating glimpse into the topic of employees' use of company-issued credit cards.
  • "Our mission was to shed light on how these cards are used, and sometimes, misused," shared Keri Stooksbury, editor-in-chief at Upgraded Points.
  • Upgraded Points surveyed 500 American employees with company-issued credit cards during a week in December 2023.
  • The survey explored card users' purchasing habits, security measures, and personal card usage and asked questions about corporate card misuse.

Sterling Bancorp Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, January 24, 2024
Banking, Professional Services, Finance, F.S.B, Income tax, Sterling Bancorp, Policy, Bank, Treasury, Expense, Trust, Insurance, Recovery, Currency, Comptroller, Government, SBT, Sterling, DOJ, Sterling Bank, Sale, Environment, Plea, Tax, Investment, Federal Home Loan Banks, NOW, Webcast, Cryptocurrency

(the “Bank”), today reported its financial results for the quarter and year ended December 31, 2023.

Key Points: 
  • (the “Bank”), today reported its financial results for the quarter and year ended December 31, 2023.
  • Recoveries during the fourth and third quarter of 2023 were $64 thousand and $1 thousand, respectively, with no charge offs in either quarter.
  • Net Interest Income and Net Interest Margin – Net interest income for the fourth quarter of 2023 was $15.1 million compared to $16.0 million for the prior quarter of 2023 and $18.5 million for the fourth quarter of 2022.
  • Non-Interest Income – Non-interest income for the fourth quarter of 2023 was $0.2 million compared to $0.4 million for the prior quarter and $0.2 million for the fourth quarter of 2022.

The North West Company Inc. Announces Third Quarter Earnings and a Quarterly Dividend

Retrieved on: 
Wednesday, December 6, 2023
Depreciation, Alaska Permanent Fund, Interest, The Company, NWC, Expense, TSX, North Star Air, GAAP, Bookkeeping

WINNIPEG, Manitoba, Dec. 06, 2023 (GLOBE NEWSWIRE) -- (TSX: NWC): The North West Company Inc. (the "Company" or "North West") today reported its unaudited financial results for the third quarter ended October 31, 2023.

Key Points: 
  • WINNIPEG, Manitoba, Dec. 06, 2023 (GLOBE NEWSWIRE) -- (TSX: NWC): The North West Company Inc. (the "Company" or "North West") today reported its unaudited financial results for the third quarter ended October 31, 2023.
  • It also announced that the Board of Directors has declared a quarterly dividend of $0.39 to shareholders of record on December 29, 2023, to be paid on January 15, 2024.
  • Higher earnings in North Star Air from an increase in third party cargo and passenger volumes and improved aircraft utilization was also a factor.
  • The Company uses the following non-GAAP financial measures: earnings before interest, income taxes, depreciation and amortization ("EBITDA"), adjusted EBITDA and adjusted net earnings.

PetVivo Reports Second Quarter of Fiscal 2024 Financial Results

Retrieved on: 
Tuesday, November 14, 2023
Ethos, Sale, Webcast, Three Months, Research, ThinkEquity, Conference call, Clinical trial, Expense, Patient, Animal, Marketing, Pain, EDINA, Average cost, Quality of life, Limp, Total revenue, Cryptocurrency, Clothing, Pharmaceutical industry, Life insurance, Conference

EDINA, MN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the three months ended September 30, 2023 (“second quarter of 2024”).

Key Points: 
  • Conference call begins at 4:00 p.m. Central time today
    EDINA, MN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the three months ended September 30, 2023 (“second quarter of 2024”).
  • Revenues were $207,366 and $223,280 for three months ended September 30, 2023 and 2022, respectively.
  • Cost of sales was $140,913 and $148,149 for the three months ended September 30, 2023 and 2022, respectively.
  • The weighted average number of shares outstanding was 12,325,973 and 10,021,090 for the six months ended September 30, 2023 and 2022, respectively.

eFFECTOR Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, November 13, 2023
Assistant, PD-L1, Associate, Therapy, Safety, D, RECIST, Fulvestrant, Effector, Expense, Investment, STRI Group, Artificial intelligence, Clinical trial, Breast cancer, Administration, D&O, Patient, PFS, Research, Science, Pembrolizumab, FA, KICKSTART, G&A, Messenger, ZFA, COVID-19, Hematology, Progression-free survival, ZF, Cancer, Death, R, AML, Research and development, MNK, Rated R, Cell, Society, Azacitidine, Pharmaceutical industry, Vaccine, Cryptocurrency, Genetics, Northwestern University, Medicine, NSCLC

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today reported financial results for the third quarter ended September 30, 2023 and provided a corporate update.

Key Points: 
  • SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today reported financial results for the third quarter ended September 30, 2023 and provided a corporate update.
  • These results, if positive, would enable activities, including interactions with regulatory agencies, intended to support initiation of a Phase 3 registrational trial.
  • Research and Development (R&D) Expenses: R&D expenses were $5.4 million for the quarter ended September 30, 2023, compared to $6.6 million for the same quarter of 2022.
  • Other Income (Expense): Other expense was $0.4 million for the quarter ended September 30, 2023, compared to $0.3 million for the same quarter of 2022.

vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, November 9, 2023
Research and development, Therapy, Insulin, Expense, Administration, VTV, G&A, General Administration of Customs, R, Receptor (biochemistry), Pharmaceutical industry

HIGH POINT, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type 1 diabetes ("T1D"), today reported financial results for the third quarter ended September 30, 2023 and provided an update on recent corporate developments.

Key Points: 
  • HIGH POINT, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type 1 diabetes ("T1D"), today reported financial results for the third quarter ended September 30, 2023 and provided an update on recent corporate developments.
  • Cash Position: The Company’s cash position as of September 30, 2023 was $8.2 million compared to $12.1 million as of December 31, 2022.
  • Net Loss: Net loss attributable to vTv shareholders for the three months ended September 30, 2023 was $6.7 million or $0.08 per basic share.
  • Net loss attributable to vTv shareholders for the comparable period a year ago was $4.3 million or $0.05 per basic share.

BILL Unveils New Features for BILL Spend & Expense to Enhance Visibility and Control of Business Finances for SMBs and Accountants

Retrieved on: 
Wednesday, December 13, 2023
Software, Data Analytics, Finance, Small Business, Accounting, Professional Services, Technology, Business, Spend, Human, State Finance Accountability Committee, NYSE, Policy, Multimedia, Trust, Luigi, Data analysis, Divvy, Travel, Construction, Expense, Growth, BILL

View the full release here: https://www.businesswire.com/news/home/20231213541015/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231213541015/en/
    “For SMBs, correctly managing spend can be the difference between success and failure.
  • The BILL Spend & Expense budgets interface has been reimagined, focusing on making budget management even more intuitive for spenders and admins.
  • “BILL Spend & Expense gives us the tools our clients need to create better visibility, controls, and workflows.
  • Watch this video to learn more about how BILL Spend & Expense can help with visibility and control of business finances.

Airbase Expands Global Expense Management with AI Innovation

Retrieved on: 
Tuesday, November 14, 2023
Technology, Payments, Finance, Fintech, Accounting, Professional Services, Software, Internet, Artificial Intelligence, Organization, Expense, Comptroller, Expense management, Machine learning, TravelPerk, OCR, IDC, Environment, Travel, Sales, Air base

Airbase expense management frees employees and accounting teams from the time-consuming drudgery of manually submitting expense reports and processing reimbursements.

Key Points: 
  • Airbase expense management frees employees and accounting teams from the time-consuming drudgery of manually submitting expense reports and processing reimbursements.
  • For businesses that support global operations and remote workers, Airbase expense management helps ensure compliance and faster reimbursements to employee bank accounts globally.
  • “To solve the complex problems of global payments and expense compliance, we rely on the most advanced and trusted technologies.
  • Airbase AI-driven expense management experience: Airbase uses generative AI and machine learning to automatically extract the details of each receipt, including generating the expense reason and details in the memo field.

Altus Power, Inc. Announces Third Quarter 2023 Financial Results

Retrieved on: 
Monday, November 13, 2023
Environment, Commercial Building & Real Estate, Technology, Construction & Property, Utilities, Alternative Energy, Software, Green Technology, Energy, Disposal, EBITDA, Accounting, Acquisition, NYSE, Equipment, Earnout, Depreciation, Bank statement, Annual report, Expense, Samsung Galaxy Note 20, PAR, Multimedia, Alignment, Interest expense, FASB, REC, GAAP, Professional, CBRE, Gain, Retirement, Redmi Note 11, Mergers and acquisitions, Growth, Entity, Accretion expense, PPA, NMCA, Renewable energy, Asset management, Bank, Insurance, Bookkeeping, Security (finance)

Altus Power, Inc. (NYSE: AMPS), the leading commercial-scale provider of clean electric power, today announced its financial results for the third quarter of 2023.

Key Points: 
  • Altus Power, Inc. (NYSE: AMPS), the leading commercial-scale provider of clean electric power, today announced its financial results for the third quarter of 2023.
  • Third quarter 2023 GAAP net income totaled $6.8 million, compared to net loss of $96.6 million for the same period last year.
  • Adjusted EBITDA* during the third quarter of 2023 was $29.1 million, compared to $19.4 million for the third quarter of 2022, a 50% increase.
  • Altus Power reaffirmed 2023 adjusted EBITDA* in the range of $97-103 million, representing approximately 70% growth over 2022.